United States Metered Dose Inhaler Devices Market Outlook to 2023

2017-07-10
Price :
Published : Jul-2017
No. of Pages : 41
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Introduction 5
2.1 What Is This Report About? 5
2.2 Metered Dose Inhaler Devices Market Segmentation 5
2.3 Definitions of Markets Covered in the Report 5
3 Metered Dose Inhaler Devices Market, United States 6
3.1 Metered Dose Inhaler Devices Market, United States, Revenue ($m), 2009-2016 6
3.2 Metered Dose Inhaler Devices Market, United States, Revenue ($m), 2016-2023 7
3.3 Metered Dose Inhaler Devices Market, United States, Volume (Units), 2009-2016 8
3.4 Metered Dose Inhaler Devices Market, United States, Volume (Units), 2016-2023 9
3.5 Metered Dose Inhaler Devices Market, United States, Average Price ($), 2009-2023 10
3.6 Metered Dose Inhaler Devices Market, United States, Distribution Share by Revenue ($m), 2015-2016 11
3.7 Metered Dose Inhaler Devices Market, United States, Company Share by Revenue ($m), 2016 12
4 Overview of Key Companies in United States, Metered Dose Inhaler Devices Market 14
4.1 GlaxoSmithKline Plc 14
4.1.1 Company Overview 14
4.2 AstraZeneca Plc 14
4.2.1 Company Overview 14
4.3 Boehringer Ingelheim GmbH 14
4.3.1 Company Overview 14
4.4 Pfizer Inc 15
4.4.1 Company Overview 15
4.5 Merck & Co Inc 15
4.5.1 Company Overview 15
4.6 Sunovion Pharmaceuticals Inc 15
4.6.1 Company Overview 15
5 Financial Deals Landscape 16
5.1 Debt Offerings 16
5.1.1 Merck Raises USD544 Million in Public Offering of 1.375% Notes Due 2036 16
5.1.2 Merck Raises USD544 Million in Public Offering of 0.5% Notes Due 2024 18
5.2 Venture Financing 20
5.2.1 Propeller Health Raises USD21.5 Million in Series C Financing 20
6 Recent Developments 21
6.1 Corporate Communications 21
6.1.1 Apr 10, 2017: Dr. John H. Noseworthy Nominated to Stand for Election to Merck Board of Directors 21
6.1.2 Apr 06, 2017: Merck Receives 2017 ENERGY STAR Sustained Excellence Award from U. S. Environmental Protection Agency 21
6.1.3 Mar 22, 2017: BioStable Science & Engineering Announces FDA Clearance of the HAART 300 Aortic Annuloplasty Device 21
6.2 Financial Announcements 22
6.2.1 May 31, 2017: Lamellar Biomedical Recruits First Patients into Clinical Study Assessing LAMELLEYE for Treatment of Dry Eye Disease 22
6.2.2 May 02, 2017: Merck Announces First-Quarter 2017 Financial Results 24
6.2.3 Apr 05, 2017: InVivo Therapeutics Announces New Patient Enrollment into the INSPIRE Study at the Carolinas Medical Center 26
6.2.4 Mar 29, 2017: Peer-Reviewed Clinical Study Shows ID Genomics' Bacterial Fingerprinting Technology Can Reduce Prescription Errors and Antibiotic Overuse at the Point-of-Care 26
6.2.5 Feb 02, 2017: Merck Announces Fourth-Quarter and Full-Year 2016 Financial Results 29
6.2.6 Oct 25, 2016: Merck Announces Third-Quarter 2016 Financial Results 30
6.3 Government and Public Interest 33
6.3.1 Mar 31, 2017: City Of Austin Announces Merck Economic Development Proposal 33
6.4 Other Significant Developments 33
6.4.1 Feb 21, 2017: PharmaCyte Biotech Discusses Patient Enrollment and TD2s Role in Upcoming Clinical Trial 33
6.4.2 Jan 25, 2017: Daktari Achieves Milestone in Its Merck HCV Collaboration 35
6.5 Strategy And Business Planning 35
6.5.1 Dec 01, 2016: Aptar Pharma Nears Completion Of Elastomer Component Capacity In North America 35
7 Appendix 37
7.1 Research Methodology 38
7.1.1 Coverage 38
7.1.2 Secondary Research 38
7.1.3 Primary Research 39
7.1.4 Company Share Analysis 39
7.1.5 Distribution Share Analysis 39
7.1.6 Benchmarking 40
7.2 GlobalData Consulting 40
7.3 Contact Us 41
7.4 Disclaimer 41

1.1 List of Tables
Table 1: Metered Dose Inhaler Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 6
Table 2: Metered Dose Inhaler Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 7
Table 3: Metered Dose Inhaler Devices Market, United States, Volume (Units), Historic, 2009-2016 8
Table 4: Metered Dose Inhaler Devices Market, United States, Volume (Units), Forecast, 2016-2023 9
Table 5: Metered Dose Inhaler Devices Market, United States, Average Price ($), Historic, 2009-2016 10
Table 6: Metered Dose Inhaler Devices Market, United States, Average Price ($), Forecast, 2016-2023 10
Table 7: Metered Dose Inhaler Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2015-2016 11
Table 8: Metered Dose Inhaler Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2016 13
Table 9: Merck Raises USD544 Million in Public Offering of 1.375% Notes Due 2036 16
Table 10: Merck Raises USD544 Million in Public Offering of 0.5% Notes Due 2024 18
Table 11: Propeller Health Raises USD21.5 Million in Series C Financing 20

1.2 List of Figures
Figure 1: Metered Dose Inhaler Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 6
Figure 2: Metered Dose Inhaler Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 7
Figure 3: Metered Dose Inhaler Devices Market, United States, Volume (Units), Historic, 2009-2016 8
Figure 4: Metered Dose Inhaler Devices Market, United States, Volume (Units), Forecast, 2016-2023 9
Figure 5: Metered Dose Inhaler Devices Market, United States, Company Share (%) 2016 12
Filed in: Medical Device
Publisher : GlobalData